MD Anderson Cancer Center/University of Texas — Houston, Texas

MD Anderson Cancer Center/University of Texas is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center/University of Texas has participated in 56 clinical trials with 6 currently active.

Therapeutic areas: Cutaneous T-Cell Lymphoma, Hodgkin Disease, Peripheral T Cell Lymphoma.

Sponsors: Novartis Pharmaceuticals, Seagen Inc., Iambic Therapeutics, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center/University of Texas?

MD Anderson Cancer Center/University of Texas has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center/University of Texas conducted?

MD Anderson Cancer Center/University of Texas has 56 clinical trials on record, with 6 currently active. Their work covers Cutaneous T-Cell Lymphoma, Hodgkin Disease, Peripheral T Cell Lymphoma.

Is MD Anderson Cancer Center/University of Texas accredited by Crixeo Clinical Trials?

MD Anderson Cancer Center/University of Texas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center/University of Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.